-transparent.png){kind=logo}
A double-blind, placebo-controlled crossover study of the effect of sulphinpyrazone on blood viscosity and its determinants (haematocrit, plasma fibrinogen and plasma viscosity) was carried out in 7 healthy male volunteers. Apart from a transient rise in fibrinogen (p less than 0.05) after 3 days of sulphinpyrazone treatment, no significant change in viscosity factors was seen over a 14-day period.
Related Publications
R V Johnston, and
G D Lowe, and
M M Drummond, and
C D Forbes, and
C R Prentice
September 1979,
The New Zealand medical journal,
R V Johnston, and
G D Lowe, and
M M Drummond, and
C D Forbes, and
C R Prentice
October 1979,
The New Zealand medical journal,
R V Johnston, and
G D Lowe, and
M M Drummond, and
C D Forbes, and
C R Prentice
January 1980,
Thrombosis research,
R V Johnston, and
G D Lowe, and
M M Drummond, and
C D Forbes, and
C R Prentice
November 1975,
Thrombosis et diathesis haemorrhagica,
R V Johnston, and
G D Lowe, and
M M Drummond, and
C D Forbes, and
C R Prentice
January 1982,
Lancet (London, England),
R V Johnston, and
G D Lowe, and
M M Drummond, and
C D Forbes, and
C R Prentice
June 1978,
European journal of clinical pharmacology,
R V Johnston, and
G D Lowe, and
M M Drummond, and
C D Forbes, and
C R Prentice
April 1969,
Hospital (Rio de Janeiro, Brazil),
R V Johnston, and
G D Lowe, and
M M Drummond, and
C D Forbes, and
C R Prentice
April 1965,
Canadian Medical Association journal,
R V Johnston, and
G D Lowe, and
M M Drummond, and
C D Forbes, and
C R Prentice
May 1964,
[Sogo rinsho] Clinic all-round,
R V Johnston, and
G D Lowe, and
M M Drummond, and
C D Forbes, and
C R Prentice
July 1984,
Bulletin of the Osaka Medical School,
